Drug General Information
Drug ID	D09HFJ
Former ID	DIB005383
Drug Name	NM-3
Drug Type	Small molecular drug
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 1	[521536]
Company	Genzyme
Structure		Download 2D MOL 3D MOL
Formula	C13H12O6
Canonical SMILES	CC(C1=CC2=CC(=CC(=C2C(=O)O1)O)OC)C(=O)O
InChIKey	BPZCXUROMKDLGX-UHFFFAOYSA-N
CAS Number	CAS 181427-78-1
PubChem Compound ID	5493470
PubChem Substance ID	11694644, 14823856, 39475206, 57364792, 78836418, 114001061, 125678626, 127551425, 134223962, 135134777, 137071769, 142130963, 162806188, 229230001, 252215914
Target and Pathway
Target(s)	VEGF ligand	Target Info	Inhibitor	[528167]
References
Ref 521536	ClinicalTrials.gov (NCT00046696) A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.. U.S. National Institutes of Health.
Ref 528167	2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes. 2006 May;55(5):1232-42.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.